BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 22135490)

  • 1. Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims.
    Mapel DW; Dalal AA; Blanchette CM; Petersen H; Ferguson GT
    Int J Chron Obstruct Pulmon Dis; 2011; 6():573-81. PubMed ID: 22135490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
    Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
    J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a claims-based prediction model for COPD severity.
    Macaulay D; Sun SX; Sorg RA; Yan SY; De G; Wu EQ; Simonelli PF
    Respir Med; 2013 Oct; 107(10):1568-77. PubMed ID: 23806285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
    Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice.
    Hernández M; García G; Falco J; García AR; Martín V; Ibarrola M; Quadrelli S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():351-356. PubMed ID: 29403272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD).
    Yu WC; Fu SN; Tai EL; Yeung YC; Kwong KC; Chang Y; Tam CM; Yiu YK
    Int J Chron Obstruct Pulmon Dis; 2013; 8():389-95. PubMed ID: 24009418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more.
    Melbye H; Drivenes E; Dalbak LG; Leinan T; Høegh-Henrichsen S; Ostrem A
    Int J Chron Obstruct Pulmon Dis; 2011; 6():597-603. PubMed ID: 22135492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spirometric variability in smokers: transitions in COPD diagnosis in a five-year longitudinal study.
    Sood A; Petersen H; Qualls C; Meek PM; Vazquez-Guillamet R; Celli BR; Tesfaigzi Y
    Respir Res; 2016 Nov; 17(1):147. PubMed ID: 27832774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.
    Högman M; Sulku J; Ställberg B; Janson C; Bröms K; Hedenström H; Lisspers K; Malinovschi A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():165-173. PubMed ID: 29379281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spirometric testing on World COPD Day.
    Grzetic-Romcevic T; Devcic B; Sonc S
    Int J Chron Obstruct Pulmon Dis; 2011; 6():141-6. PubMed ID: 21468166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
    Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Spirometry in Patients With Known or Suspected Chronic Obstructive Pulmonary Disease Undergoing Major Surgery: The Prospective Observational PREDICT Study.
    Dankert A; Neumann-Schirmbeck B; Dohrmann T; Greiwe G; Plümer L; Löser B; Sehner S; Zöllner C; Petzoldt M
    Anesth Analg; 2023 Oct; 137(4):806-818. PubMed ID: 36730893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tele health care on exacerbations and hospital admissions in patients with chronic obstructive pulmonary disease: a randomized clinical trial.
    Ringbæk T; Green A; Laursen LC; Frausing E; Brøndum E; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1801-8. PubMed ID: 26366072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey.
    Park HJ; Leem AY; Lee SH; Song JH; Park MS; Kim YS; Kim SK; Chang J; Chung KS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1571-82. PubMed ID: 26300636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care?
    Kjeldgaard P; Lykkegaard J; Spillemose H; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2323-2331. PubMed ID: 28831249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the heterogeneity of COPD by V/P SPECT: a new tool for improving the diagnosis of parenchymal defects and grading the severity of small airways disease.
    Bajc M; Chen Y; Wang J; Li XY; Shen WM; Wang CZ; Huang H; Lindqvist A; He XY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1579-1587. PubMed ID: 28603413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.